DRUG DESIGN AND DEVELOPMENT: PRECLINICAL ASPECT
DRUG DESIGN AND DEVELOPMENT, PRECLINICAL ASPECT is intended to give propelled training to
enrolled individuals by preclinical parts of translational medicine and related research.
This program is intended to create specialists for the high-demand field of drug development. The
program is organized particularly for working experts who wish to take a couple of courses in
advantageous weekends or as an online course from distance.
COURSE OUTCOME
After completing this course, the learners will get acquainted with the following:
- It gets ready people for jobs in preclinical and clinical issues and early stage production.
- It makes individual specialists in drug development and its usage.
- Good knowledge in developing novel drug and its understanding at gene level
COURSE OUTLINE Module 1 – An introductory course
Module 2 – Detailed learning of drug design and development.
Module 3 – Overview of the translational medicine
Module 4 – Preclinical aspect of drug development
Module 6 – Conclusion
Certification Exam/ Assessment
CERTIFICATION
WHO SHOULD TAKE THIS COURSE
Pharma Graduates
M. Pharma and D. Pharma students
Researchers
Level: Beginner
Language: English
Duration: 6 Months
M. Pharma and D. Pharma students
Researchers
Level: Beginner
Language: English
Duration: 6 Months
EVALUATION METHOD
Learners must attempt the exam at the end of the course and secure at least 50% marks to obtain the
course certificate.
course certificate.
ABOUT THE AUTHOR
CELNET (Consortium e-Learning Network Private Limited) is an education empowerment
organization committed to equip the students with the right tools and resources to augment and utilize
knowledge to its full potential. CELNET is among the fastest growing and innovative publishers of journals
and now proud to introduce web-based training programs.
